文献速递泌尿系结石

定制缝线支架减少输尿管支架相关症状的随机对照优越性试验

Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized 'suture stent'.
PubMed 文献 · BJU Int · 2020-12-15

一项前瞻性随机单盲优越性试验纳入88例需在二次输尿管软镜前置入支架的泌尿系结石患者,比较定制缝线支架与标准输尿管支架。结果显示缝线支架组在置入后1周及二次URS前的USSQ尿路症状评分及疼痛评分显著更低,不良事件与输尿管通路无显著差异。

要点

  • 缝线支架可显著降低支架相关尿路症状和疼痛评分。
  • 缝线支架不增加不良事件,且不影响二次URS的输尿管通路。
  • 缝线支架置入操作时间较长(24.0 vs 14.5 min)。

核心结论

  • 用缝线替代输尿管支架远端部分可减少支架相关症状,且不限制二次取石或影响安全性。

研究设计与样本

  • 前瞻性、随机、单盲、优越性试验,纳入88例髂血管交叉以上泌尿系结石需在二次输尿管软镜前置入支架的患者。

主要发现

  • 缝线支架长度中位数10 cm(范围5-25 cm),标准支架26 cm。
  • 置入后1周,缝线支架组基线校正USSQ尿路症状评分显著更低(均值7.1 vs 13.7,差值-6.6,95%CI -3.4至-9.8;P<0.001)。
  • 二次URS前(2-6周后),缝线支架组基线校正尿路症状评分(均值4.7 vs 12.2,差值-7.5,95%CI -4.5至-10.4;P<0.001)和疼痛子评分(11.5 vs 17.6,差值-6.1,95%CI -0.7至-11.6;P=0.004)显著更低。
  • 其他USSQ子评分无显著差异;不良事件发生15例,两组频率相似;二次URS时输尿管通路无显著差异。
  • 缝线支架置入手术时间更长(24.0 vs 14.5 min;P<0.001)。

临床怎么用

  • 对于需在二次URS前置入输尿管支架的泌尿系结石患者,可考虑使用缝线支架以减少支架相关症状和疼痛。

局限性

  • 样本量有限(88例),单中心设计,随访时间较短(至支架取出后2-6周)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare a customized 'suture stent' with a standard ureteric stent regarding stent-related symptoms, safety and efficacy. MATERIALS AND METHODS: Patients with urolithiasis located proximal to the iliac vessel crossing, requiring stenting in preparation for secondary ureterorenoscopy (URS) were randomized to standard ureteric stenting or a suture stent. Secondary ureterorenoscopy was performed 2-6 weeks later. The Ureteral Stent Symptoms Questionnaire (USSQ) was completed after 1 week, on the day before URS and 2-6 weeks after stent removal. Stent efficacy and safety were systematically assessed. RESULTS: A total of 88 patients were included in the analysis. The median (range) suture stent length was 10 (5-25) cm vs 26 cm for standard stents. Operation time was longer for insertion of the suture stent (24.0 vs 14.5 min; P < 0.001). Patients with a suture stent had a significantly lower USSQ urinary symptoms score 1 week after stent insertion, adjusted for baseline symptoms by subtracting scores from the final visit without indwelling stent (mean 7.1 vs 13.7, difference -6.6, 95% confidence interval [CI] -3.4 to -9.8; P < 0.001). Prior to secondary URS (after 2-6 weeks), baseline-adjusted urinary symptoms (mean 4.7 vs 12.2, difference -7.5, 95% CI -4.5 to -10.4; P < 0.001) and pain subscores (11.5 vs 17.6, difference -6.1, 95% CI -0.7 to -11.6; P = 0.004) were significantly lower in the suture stent group. All other USSQ subscores showed no significant differences. Adverse events occurred in 15 patients and were similarly frequent in the two groups. No significant differences were found between the groups regarding ureteric access during secondary URS. CONCLUSION: Replacement of the distal part of ureteric stents by a suture can reduce stent-associated symptoms without restrictions regarding secondary stone removal or safety.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Betschart P, Piller A, Zumstein V, et al. Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized 'suture stent'. BJU Int. 2020. PMID: 33152169. doi:10.1111/bju.15290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。